
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Shaily Engineering Plastics Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Healthcare segment revenue grew 158% Y-o-Y for 9 months FY '26, indicating high growth potential. Key concall takeaways from Shaily Engineering Plastics Ltd's…
7 Aug 2026
SMS Pharmaceuticals Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Revenue from operations for H1 FY '26 grew 21% year-on-year to INR 438.4 crores. Key concall takeaways from SMS Pharmaceuticals Ltd's Q2 FY26 earnings call…
7 Aug 2026
Fractal Analytics Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Recent growth drivers include strong expansion in healthcare and life sciences (78% YoY growth) and banking/financial services (26% YoY growth). Key concall…
7 Aug 2026
Amagi Media Labs Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company currently has a strong cash balance (INR803 crores as of the quarter-end), excluding the primary capital raise from the January IPO. Key concall…
7 Aug 2026
Shilpa Medicare Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
EBITDA margins of 26%-27% are sustainable, with opportunities to improve further (Page 16). Key concall takeaways from Shilpa Medicare Ltd's Q3 FY25 earnings…
7 Aug 2026
Admach Systems Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Around 50% of business comes from special grade steel processing equipment and 30% from NDT and defense sectors. Key concall takeaways from Admach Systems…
7 Aug 2026
Dachepalli Publishers Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
90% to 95% of the business (textbook sales) occurs in Q4 and Q1 due to academic calendar seasonality. Key concall takeaways from Dachepalli Publishers Ltd's Q3…
7 Aug 2026
Park Medi World Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
FY26 capex of ~INR 280 crores for Agra and Panchkula units; FY27 capex primarily for Kanpur and Delhi (~INR 110 crores). Key concall takeaways from Park Medi…
7 Aug 2026
Physicswallah Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Test prep has grown at a ~97% CAGR over the last two years. Key concall takeaways from Physicswallah Ltd's Q3 FY26 earnings call — and how it ranks against…
7 Aug 2026
HEG Advanced Materials Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
market accounts for 10-12% of sales; company is well-diversified with presence in 35 countries, reducing dependence on any single market. Key concall takeaways…
7 Aug 2026
Nephrocare Health Services Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Patient volumes grew at a CAGR of ~20% from FY ‘23 to FY ‘25 and continued to grow 15% YoY in 9-month FY ‘26. Key concall takeaways from Nephrocare Health…
7 Aug 2026
Wakefit Innovations Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Operating EBITDA margin for Q3 FY '26 stood at 9.9%, up from 2.1% last year; PAT margin was 7.6%. Key concall takeaways from Wakefit Innovations Ltd's Q3 FY26…
7 Aug 2026
Aequs Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Continuous CapEx planned, especially in aerospace, to meet increasing demand and maintain capacity utilization around 75%. Key concall takeaways from Aequs…
7 Aug 2026
Capillary Technologies India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Revenue grew 16% year-on-year in Q3 FY26, with 22% growth for the nine months period. Key concall takeaways from Capillary Technologies India Ltd's Q3 FY26…
7 Aug 2026
JTEKT India Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
JTEKT supplies about 50%-55% of Maruti Suzuki's requirements, so growth is closely tied to Maruti, Toyota, and other OEMs. Key concall takeaways from JTEKT…
7 Aug 2026
Shivalik Bimetal Controls Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
FY25 EBITDA grew 25% YoY with margin expansion over 400 bps to 23.17%; PBT rose 30% with margins over 20%. Key concall takeaways from Shivalik Bimetal Controls…
7 Aug 2026
Relaxo Footwears Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Addition of around 100 new distributors and expansion of retail outlets by 5-10% planned. Key concall takeaways from Relaxo Footwears Ltd's Q4 FY25 earnings…
7 Aug 2026
Sudeep Pharma Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Currently 35%-40% utilization; no major capex planned. Key concall takeaways from Sudeep Pharma Ltd's Q3 FY26 earnings call — and how it ranks against sector…
7 Aug 2026
Fujiyama Power Systems Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
300 crores (completed faster than industrial standards). Key concall takeaways from Fujiyama Power Systems Ltd's Q3 FY26 earnings call — and how it ranks…
7 Aug 2026
Fujiyama Power Systems Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Historically, Fujiyama Power Systems has achieved strong year-on-year growth, with recent quarterly revenue growth of 72.6% and half-year growth of 61.5% (Page…
7 Aug 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access